SCHEMBL7189666

SCHEMBL7189666

C[CH]c1cc(C)c(C)c(Br)c1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1610054 0.82 TUBB1 (0.41) TUBB1
SCHEMBL15370277 0.79 SRC (0.41) TUBB1
SCHEMBL10018816 0.74 ALDH1A1 (0.46)
SCHEMBL11041539 0.74 APEX1 (0.45)
SCHEMBL10871325 0.71 ALDH1A1 (0.50) TUBB1
SCHEMBL15370274 0.70 EGFR (0.57)
SCHEMBL12659277 0.70 KDM4E (0.54)
SCHEMBL459156 0.69 RAPGEF4 (0.39)
SCHEMBL5780229 0.69 AHR (0.44)
SCHEMBL10551448 0.67 CA1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583179-B2 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-06-24 US disclosed